Invention Grant
US09274113B2 Method for screening an agent preventing or treating cancer using glycyl-tRNA synthetase and cadherin
有权
使用甘氨酰tRNA合成酶和钙粘蛋白筛选预防或治疗癌症的药物的方法
- Patent Title: Method for screening an agent preventing or treating cancer using glycyl-tRNA synthetase and cadherin
- Patent Title (中): 使用甘氨酰tRNA合成酶和钙粘蛋白筛选预防或治疗癌症的药物的方法
-
Application No.: US14249975Application Date: 2014-04-10
-
Publication No.: US09274113B2Publication Date: 2016-03-01
- Inventor: Sunghoon Kim , Min Chul Park
- Applicant: Medicinal Bioconvergence Research Center
- Applicant Address: KR Suwon-si
- Assignee: Medicinal Bioconvergence Research Center
- Current Assignee: Medicinal Bioconvergence Research Center
- Current Assignee Address: KR Suwon-si
- Agency: H.C. Park & Associates, PLC
- Priority: KR10-2011-0103306 20111010
- Main IPC: G01N33/573
- IPC: G01N33/573 ; G01N33/68
Abstract:
The present invention relates to a novel method of screening an agent for preventing or treating cancer using glycyl-tRNA synthetase (GRS) and cadherin (CDH). More particularly, it relates to a method of screening and test agent which modulates the binding level of GRS or their fragment with CDH. As can be seen foregoing, the present invention relates to a novel use of GRS and CDH and provides a method of screening an agent for preventing or treating cancer. The method may be used for developing novel agent for treatment of various cancer.
Public/Granted literature
- US20140220596A1 METHOD FOR SCREENING AN AGENT PREVENTING OR TREATING CANCER USING GLYCYL-TRNA SYNTHETASE AND CADHERIN Public/Granted day:2014-08-07
Information query
IPC分类:
